Biotech company Moderna says White House coronavirus vaccine chief is divesting

The former pharmaceutical executive leading the White House’s coronavirus vaccine effort is divesting from vaccine developer Moderna Inc., the biotech company said Monday after early-stage test results sent its stock soaring. Moncef Slaoui resigned from Moderna’s board of directors when the Trump administration tapped him last week to be chief adviser for its Operation Warp Speed, a push to …